Cargando…

Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients

In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosina, Erica, Pezzani, Lidia, Pezzoli, Laura, Marchetti, Daniela, Bellini, Matteo, Pilotta, Alba, Calabrese, Olga, Nicastro, Emanuele, Cirillo, Francesco, Cereda, Anna, Scatigno, Agnese, Milani, Donatella, Iascone, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319862/
https://www.ncbi.nlm.nih.gov/pubmed/35886058
http://dx.doi.org/10.3390/genes13071275
_version_ 1784755653732990976
author Rosina, Erica
Pezzani, Lidia
Pezzoli, Laura
Marchetti, Daniela
Bellini, Matteo
Pilotta, Alba
Calabrese, Olga
Nicastro, Emanuele
Cirillo, Francesco
Cereda, Anna
Scatigno, Agnese
Milani, Donatella
Iascone, Maria
author_facet Rosina, Erica
Pezzani, Lidia
Pezzoli, Laura
Marchetti, Daniela
Bellini, Matteo
Pilotta, Alba
Calabrese, Olga
Nicastro, Emanuele
Cirillo, Francesco
Cereda, Anna
Scatigno, Agnese
Milani, Donatella
Iascone, Maria
author_sort Rosina, Erica
collection PubMed
description In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single patient have been estimated to occur in approximately 2–7.5% of diagnosed cases, with higher frequency in consanguineous families. Here, we report the clinical and molecular characterisation of eight illustrative patients for whom trio-WES allowed for identifing more than one genetic condition. Double homozygosity represented the causal mechanism in only half of them, whereas the other half showed peculiar multilocus combinations. The paper takes into consideration difficulties and learned lessons from our experience and therefore supports the powerful role of wide analyses for ascertaining multiple genetic diseases in complex patients, especially when a clinical suspicion could account for the majority of clinical signs. It finally makes clear how a patient’s “deep phenotyping” might not be sufficient to suggest the presence of multiple genetic diagnoses but remains essential to validate an unexpected multilocus result from genetic tests.
format Online
Article
Text
id pubmed-9319862
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93198622022-07-27 Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients Rosina, Erica Pezzani, Lidia Pezzoli, Laura Marchetti, Daniela Bellini, Matteo Pilotta, Alba Calabrese, Olga Nicastro, Emanuele Cirillo, Francesco Cereda, Anna Scatigno, Agnese Milani, Donatella Iascone, Maria Genes (Basel) Article In the last few years, trio-Whole Exome Sequencing (WES) analysis has revolutionized the diagnostic process for patients with rare genetic syndromes, demonstrating its potential even in non-specific clinical pictures and in atypical presentations of known diseases. Multiple disorders in a single patient have been estimated to occur in approximately 2–7.5% of diagnosed cases, with higher frequency in consanguineous families. Here, we report the clinical and molecular characterisation of eight illustrative patients for whom trio-WES allowed for identifing more than one genetic condition. Double homozygosity represented the causal mechanism in only half of them, whereas the other half showed peculiar multilocus combinations. The paper takes into consideration difficulties and learned lessons from our experience and therefore supports the powerful role of wide analyses for ascertaining multiple genetic diseases in complex patients, especially when a clinical suspicion could account for the majority of clinical signs. It finally makes clear how a patient’s “deep phenotyping” might not be sufficient to suggest the presence of multiple genetic diagnoses but remains essential to validate an unexpected multilocus result from genetic tests. MDPI 2022-07-19 /pmc/articles/PMC9319862/ /pubmed/35886058 http://dx.doi.org/10.3390/genes13071275 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rosina, Erica
Pezzani, Lidia
Pezzoli, Laura
Marchetti, Daniela
Bellini, Matteo
Pilotta, Alba
Calabrese, Olga
Nicastro, Emanuele
Cirillo, Francesco
Cereda, Anna
Scatigno, Agnese
Milani, Donatella
Iascone, Maria
Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
title Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
title_full Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
title_fullStr Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
title_full_unstemmed Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
title_short Atypical, Composite, or Blended Phenotypes: How Different Molecular Mechanisms Could Associate in Double-Diagnosed Patients
title_sort atypical, composite, or blended phenotypes: how different molecular mechanisms could associate in double-diagnosed patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319862/
https://www.ncbi.nlm.nih.gov/pubmed/35886058
http://dx.doi.org/10.3390/genes13071275
work_keys_str_mv AT rosinaerica atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT pezzanilidia atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT pezzolilaura atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT marchettidaniela atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT bellinimatteo atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT pilottaalba atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT calabreseolga atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT nicastroemanuele atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT cirillofrancesco atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT ceredaanna atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT scatignoagnese atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT milanidonatella atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients
AT iasconemaria atypicalcompositeorblendedphenotypeshowdifferentmolecularmechanismscouldassociateindoublediagnosedpatients